Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Recipient MTHFR polymorphisms (C677T) were associated with acute GvHD (P=0.03), and recipient VDR TaqI with TRM and overall survival (P=0.006 and P=0.04, respectively).Genetic factors that interfere with drug metabolisms are associated with treatment-related toxicities, GvHD and survival after HLA-identical HSCT in patients with leukemia and should be investigated prospectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP850651.RACJLtpemn08bUenRrSPRgYX_oa74aMNgWytdlVRUEJ6c130_assertion description "[Recipient MTHFR polymorphisms (C677T) were associated with acute GvHD (P=0.03), and recipient VDR TaqI with TRM and overall survival (P=0.006 and P=0.04, respectively).Genetic factors that interfere with drug metabolisms are associated with treatment-related toxicities, GvHD and survival after HLA-identical HSCT in patients with leukemia and should be investigated prospectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP850651.RACJLtpemn08bUenRrSPRgYX_oa74aMNgWytdlVRUEJ6c130_provenance.
• NP242776.RAla6jyhXcUMNA11l4_8ENJmgD9KVraA017odUHY0nzEc130_assertion description "[Recipient MTHFR polymorphisms (C677T) were associated with acute GvHD (P=0.03), and recipient VDR TaqI with TRM and overall survival (P=0.006 and P=0.04, respectively).Genetic factors that interfere with drug metabolisms are associated with treatment-related toxicities, GvHD and survival after HLA-identical HSCT in patients with leukemia and should be investigated prospectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP242776.RAla6jyhXcUMNA11l4_8ENJmgD9KVraA017odUHY0nzEc130_provenance.
• NP649438.RATLHOrY-2eA6drYCzeby4A5vpsg-WJ6iX6P1rz1QXCEo130_assertion description "[Recipient MTHFR polymorphisms (C677T) were associated with acute GvHD (P=0.03), and recipient VDR TaqI with TRM and overall survival (P=0.006 and P=0.04, respectively).Genetic factors that interfere with drug metabolisms are associated with treatment-related toxicities, GvHD and survival after HLA-identical HSCT in patients with leukemia and should be investigated prospectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP649438.RATLHOrY-2eA6drYCzeby4A5vpsg-WJ6iX6P1rz1QXCEo130_provenance.
• NP690316.RAS0jOz1M2IJi9fF3Ozs4FPOc_57Vr-80hcOKPpd-YU2w130_assertion description "[Recipient MTHFR polymorphisms (C677T) were associated with acute GvHD (P=0.03), and recipient VDR TaqI with TRM and overall survival (P=0.006 and P=0.04, respectively).Genetic factors that interfere with drug metabolisms are associated with treatment-related toxicities, GvHD and survival after HLA-identical HSCT in patients with leukemia and should be investigated prospectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP690316.RAS0jOz1M2IJi9fF3Ozs4FPOc_57Vr-80hcOKPpd-YU2w130_provenance.
• NP587114.RAbQKHGjdDyZYlFZn-l5x2o3NrTD9p-266-jlEBIBILG0130_assertion description "[Recipient MTHFR polymorphisms (C677T) were associated with acute GvHD (P=0.03), and recipient VDR TaqI with TRM and overall survival (P=0.006 and P=0.04, respectively).Genetic factors that interfere with drug metabolisms are associated with treatment-related toxicities, GvHD and survival after HLA-identical HSCT in patients with leukemia and should be investigated prospectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP587114.RAbQKHGjdDyZYlFZn-l5x2o3NrTD9p-266-jlEBIBILG0130_provenance.
• NP240521.RA28IkVrDa2pwAjH5G-Aq1zhXOQITTTaU_mF6H4tAwf8M130_assertion description "[Recipient MTHFR polymorphisms (C677T) were associated with acute GvHD (P=0.03), and recipient VDR TaqI with TRM and overall survival (P=0.006 and P=0.04, respectively).Genetic factors that interfere with drug metabolisms are associated with treatment-related toxicities, GvHD and survival after HLA-identical HSCT in patients with leukemia and should be investigated prospectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP240521.RA28IkVrDa2pwAjH5G-Aq1zhXOQITTTaU_mF6H4tAwf8M130_provenance.
• NP776577.RA3F8cTOybaM6UPSRuBxWOTLe3pnk9d4lm7ZVG5FWMMrk130_assertion description "[Recipient MTHFR polymorphisms (C677T) were associated with acute GvHD (P=0.03), and recipient VDR TaqI with TRM and overall survival (P=0.006 and P=0.04, respectively).Genetic factors that interfere with drug metabolisms are associated with treatment-related toxicities, GvHD and survival after HLA-identical HSCT in patients with leukemia and should be investigated prospectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP776577.RA3F8cTOybaM6UPSRuBxWOTLe3pnk9d4lm7ZVG5FWMMrk130_provenance.
• NP574829.RAYVDiAlI0kB6ZT1-TI5SqANZAQaAvv9mRz-1zo_SL2ag130_assertion description "[Recipient MTHFR polymorphisms (C677T) were associated with acute GvHD (P=0.03), and recipient VDR TaqI with TRM and overall survival (P=0.006 and P=0.04, respectively).Genetic factors that interfere with drug metabolisms are associated with treatment-related toxicities, GvHD and survival after HLA-identical HSCT in patients with leukemia and should be investigated prospectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP574829.RAYVDiAlI0kB6ZT1-TI5SqANZAQaAvv9mRz-1zo_SL2ag130_provenance.
• assertion description "[Recipient MTHFR polymorphisms (C677T) were associated with acute GvHD (P=0.03), and recipient VDR TaqI with TRM and overall survival (P=0.006 and P=0.04, respectively).Genetic factors that interfere with drug metabolisms are associated with treatment-related toxicities, GvHD and survival after HLA-identical HSCT in patients with leukemia and should be investigated prospectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Recipient MTHFR polymorphisms (C677T) were associated with acute GvHD (P=0.03), and recipient VDR TaqI with TRM and overall survival (P=0.006 and P=0.04, respectively).Genetic factors that interfere with drug metabolisms are associated with treatment-related toxicities, GvHD and survival after HLA-identical HSCT in patients with leukemia and should be investigated prospectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP655631.RAPH569oSnf9g2lfDO1CiPbEr-a6okkkvx_T7sb9-IxF0130_assertion description "[Recipient MTHFR polymorphisms (C677T) were associated with acute GvHD (P=0.03), and recipient VDR TaqI with TRM and overall survival (P=0.006 and P=0.04, respectively).Genetic factors that interfere with drug metabolisms are associated with treatment-related toxicities, GvHD and survival after HLA-identical HSCT in patients with leukemia and should be investigated prospectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP655631.RAPH569oSnf9g2lfDO1CiPbEr-a6okkkvx_T7sb9-IxF0130_provenance.
• assertion description "[Recipient MTHFR polymorphisms (C677T) were associated with acute GvHD (P=0.03), and recipient VDR TaqI with TRM and overall survival (P=0.006 and P=0.04, respectively).Genetic factors that interfere with drug metabolisms are associated with treatment-related toxicities, GvHD and survival after HLA-identical HSCT in patients with leukemia and should be investigated prospectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Recipient MTHFR polymorphisms (C677T) were associated with acute GvHD (P=0.03), and recipient VDR TaqI with TRM and overall survival (P=0.006 and P=0.04, respectively).Genetic factors that interfere with drug metabolisms are associated with treatment-related toxicities, GvHD and survival after HLA-identical HSCT in patients with leukemia and should be investigated prospectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Recipient MTHFR polymorphisms (C677T) were associated with acute GvHD (P=0.03), and recipient VDR TaqI with TRM and overall survival (P=0.006 and P=0.04, respectively).Genetic factors that interfere with drug metabolisms are associated with treatment-related toxicities, GvHD and survival after HLA-identical HSCT in patients with leukemia and should be investigated prospectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Recipient MTHFR polymorphisms (C677T) were associated with acute GvHD (P=0.03), and recipient VDR TaqI with TRM and overall survival (P=0.006 and P=0.04, respectively).Genetic factors that interfere with drug metabolisms are associated with treatment-related toxicities, GvHD and survival after HLA-identical HSCT in patients with leukemia and should be investigated prospectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Recipient MTHFR polymorphisms (C677T) were associated with acute GvHD (P=0.03), and recipient VDR TaqI with TRM and overall survival (P=0.006 and P=0.04, respectively).Genetic factors that interfere with drug metabolisms are associated with treatment-related toxicities, GvHD and survival after HLA-identical HSCT in patients with leukemia and should be investigated prospectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Recipient MTHFR polymorphisms (C677T) were associated with acute GvHD (P=0.03), and recipient VDR TaqI with TRM and overall survival (P=0.006 and P=0.04, respectively).Genetic factors that interfere with drug metabolisms are associated with treatment-related toxicities, GvHD and survival after HLA-identical HSCT in patients with leukemia and should be investigated prospectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Recipient MTHFR polymorphisms (C677T) were associated with acute GvHD (P=0.03), and recipient VDR TaqI with TRM and overall survival (P=0.006 and P=0.04, respectively).Genetic factors that interfere with drug metabolisms are associated with treatment-related toxicities, GvHD and survival after HLA-identical HSCT in patients with leukemia and should be investigated prospectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Recipient MTHFR polymorphisms (C677T) were associated with acute GvHD (P=0.03), and recipient VDR TaqI with TRM and overall survival (P=0.006 and P=0.04, respectively).Genetic factors that interfere with drug metabolisms are associated with treatment-related toxicities, GvHD and survival after HLA-identical HSCT in patients with leukemia and should be investigated prospectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP75896.RA2dcYjP4ykheiATWkxACxVJT0y9wUGcfh5vZfYTg8xW4130_assertion description "[Recipient MTHFR polymorphisms (C677T) were associated with acute GvHD (P=0.03), and recipient VDR TaqI with TRM and overall survival (P=0.006 and P=0.04, respectively).Genetic factors that interfere with drug metabolisms are associated with treatment-related toxicities, GvHD and survival after HLA-identical HSCT in patients with leukemia and should be investigated prospectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP75896.RA2dcYjP4ykheiATWkxACxVJT0y9wUGcfh5vZfYTg8xW4130_provenance.
• NP75915.RA-IAxjoyYTetNpPW2Zxppx6PUsv3Z3i3irjLxqBscV2I130_assertion description "[Recipient MTHFR polymorphisms (C677T) were associated with acute GvHD (P=0.03), and recipient VDR TaqI with TRM and overall survival (P=0.006 and P=0.04, respectively).Genetic factors that interfere with drug metabolisms are associated with treatment-related toxicities, GvHD and survival after HLA-identical HSCT in patients with leukemia and should be investigated prospectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP75915.RA-IAxjoyYTetNpPW2Zxppx6PUsv3Z3i3irjLxqBscV2I130_provenance.
• NP79284.RALWq0bBaGVVuJYQmz9yKLDYq40YiKctIHE-QtTzU3hWw130_assertion description "[Recipient MTHFR polymorphisms (C677T) were associated with acute GvHD (P=0.03), and recipient VDR TaqI with TRM and overall survival (P=0.006 and P=0.04, respectively).Genetic factors that interfere with drug metabolisms are associated with treatment-related toxicities, GvHD and survival after HLA-identical HSCT in patients with leukemia and should be investigated prospectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP79284.RALWq0bBaGVVuJYQmz9yKLDYq40YiKctIHE-QtTzU3hWw130_provenance.
• NP703068.RAqK7a_qhKuWDkVmY-OuX9jt9GAYBQhhcHNAc-XV6KazQ130_assertion description "[Recipient MTHFR polymorphisms (C677T) were associated with acute GvHD (P=0.03), and recipient VDR TaqI with TRM and overall survival (P=0.006 and P=0.04, respectively).Genetic factors that interfere with drug metabolisms are associated with treatment-related toxicities, GvHD and survival after HLA-identical HSCT in patients with leukemia and should be investigated prospectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP703068.RAqK7a_qhKuWDkVmY-OuX9jt9GAYBQhhcHNAc-XV6KazQ130_provenance.
• NP85130.RAyMoibaFekZz3C4Wo4Rut8PxgfbVOn-ff_LI9fns7jf4130_assertion description "[Recipient MTHFR polymorphisms (C677T) were associated with acute GvHD (P=0.03), and recipient VDR TaqI with TRM and overall survival (P=0.006 and P=0.04, respectively).Genetic factors that interfere with drug metabolisms are associated with treatment-related toxicities, GvHD and survival after HLA-identical HSCT in patients with leukemia and should be investigated prospectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85130.RAyMoibaFekZz3C4Wo4Rut8PxgfbVOn-ff_LI9fns7jf4130_provenance.
• NP574949.RA9F-hB0-q-jsL--RGs49Rsy4H5rJ_JUng6YTJpIJ0rRo130_assertion description "[Recipient MTHFR polymorphisms (C677T) were associated with acute GvHD (P=0.03), and recipient VDR TaqI with TRM and overall survival (P=0.006 and P=0.04, respectively).Genetic factors that interfere with drug metabolisms are associated with treatment-related toxicities, GvHD and survival after HLA-identical HSCT in patients with leukemia and should be investigated prospectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP574949.RA9F-hB0-q-jsL--RGs49Rsy4H5rJ_JUng6YTJpIJ0rRo130_provenance.
• NP576062.RAxU8WDmLMptpbQaSrEKrhV_HtTTeEnxJIt7jrd4zOHtg130_assertion description "[Recipient MTHFR polymorphisms (C677T) were associated with acute GvHD (P=0.03), and recipient VDR TaqI with TRM and overall survival (P=0.006 and P=0.04, respectively).Genetic factors that interfere with drug metabolisms are associated with treatment-related toxicities, GvHD and survival after HLA-identical HSCT in patients with leukemia and should be investigated prospectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP576062.RAxU8WDmLMptpbQaSrEKrhV_HtTTeEnxJIt7jrd4zOHtg130_provenance.
• NP133264.RAE5jfVnRb-XnF3mC0hVkYtyQhpO1uW4eUFhh2tiyTnaY130_assertion description "[Recipient MTHFR polymorphisms (C677T) were associated with acute GvHD (P=0.03), and recipient VDR TaqI with TRM and overall survival (P=0.006 and P=0.04, respectively).Genetic factors that interfere with drug metabolisms are associated with treatment-related toxicities, GvHD and survival after HLA-identical HSCT in patients with leukemia and should be investigated prospectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP133264.RAE5jfVnRb-XnF3mC0hVkYtyQhpO1uW4eUFhh2tiyTnaY130_provenance.
• NP703067.RAGy4uMWJgSdfnZv2cAPHvjqSvhmpvx3Ocn9P3zxBNclA130_assertion description "[Recipient MTHFR polymorphisms (C677T) were associated with acute GvHD (P=0.03), and recipient VDR TaqI with TRM and overall survival (P=0.006 and P=0.04, respectively).Genetic factors that interfere with drug metabolisms are associated with treatment-related toxicities, GvHD and survival after HLA-identical HSCT in patients with leukemia and should be investigated prospectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP703067.RAGy4uMWJgSdfnZv2cAPHvjqSvhmpvx3Ocn9P3zxBNclA130_provenance.
• NP133270.RA-LpPi3YGfMs1i8ofJu4Jy8wFHS9KvVw_2e2ferdBEGw130_assertion description "[Recipient MTHFR polymorphisms (C677T) were associated with acute GvHD (P=0.03), and recipient VDR TaqI with TRM and overall survival (P=0.006 and P=0.04, respectively).Genetic factors that interfere with drug metabolisms are associated with treatment-related toxicities, GvHD and survival after HLA-identical HSCT in patients with leukemia and should be investigated prospectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP133270.RA-LpPi3YGfMs1i8ofJu4Jy8wFHS9KvVw_2e2ferdBEGw130_provenance.
• NP133275.RA2TPFrpHLZD3g3wHmoKbH1orhrHdMvU_TDgcbei6EvA4130_assertion description "[Recipient MTHFR polymorphisms (C677T) were associated with acute GvHD (P=0.03), and recipient VDR TaqI with TRM and overall survival (P=0.006 and P=0.04, respectively).Genetic factors that interfere with drug metabolisms are associated with treatment-related toxicities, GvHD and survival after HLA-identical HSCT in patients with leukemia and should be investigated prospectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP133275.RA2TPFrpHLZD3g3wHmoKbH1orhrHdMvU_TDgcbei6EvA4130_provenance.
• NP133277.RAzgtRM5wW7FUtt9rOrf8NNbtuFiQzGmVkRzoqPFdQmoI130_assertion description "[Recipient MTHFR polymorphisms (C677T) were associated with acute GvHD (P=0.03), and recipient VDR TaqI with TRM and overall survival (P=0.006 and P=0.04, respectively).Genetic factors that interfere with drug metabolisms are associated with treatment-related toxicities, GvHD and survival after HLA-identical HSCT in patients with leukemia and should be investigated prospectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP133277.RAzgtRM5wW7FUtt9rOrf8NNbtuFiQzGmVkRzoqPFdQmoI130_provenance.
• NP703071.RA_p6Vq8pJCDwM2IlNBnehYKG_sodeoApnlZheVHpGx9E130_assertion description "[Recipient MTHFR polymorphisms (C677T) were associated with acute GvHD (P=0.03), and recipient VDR TaqI with TRM and overall survival (P=0.006 and P=0.04, respectively).Genetic factors that interfere with drug metabolisms are associated with treatment-related toxicities, GvHD and survival after HLA-identical HSCT in patients with leukemia and should be investigated prospectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP703071.RA_p6Vq8pJCDwM2IlNBnehYKG_sodeoApnlZheVHpGx9E130_provenance.